LENSAR, Inc. (LNSR)
NASDAQ: LNSR · Real-Time Price · USD
12.31
+0.26 (2.16%)
At close: Oct 31, 2025, 4:00 PM EDT
12.30
-0.01 (-0.08%)
After-hours: Oct 31, 2025, 4:31 PM EDT
LENSAR Market Cap
LENSAR has a market cap or net worth of $146.8 million as of October 31, 2025. Its market cap has increased by 144.60% in one year.
Market Cap
146.80M
Enterprise Value
128.82M
1-Year Change
144.60%
Ranking
Category
Stock Price
$12.31
Market Cap Chart
Since October 2, 2020, LENSAR's market cap has increased from $78.01M to $146.80M, an increase of 88.19%. That is a compound annual growth rate of 13.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2025 | 143.81M | 38.50% |
| Dec 31, 2024 | 103.84M | 163.00% |
| Dec 29, 2023 | 39.48M | 21.00% |
| Dec 30, 2022 | 32.63M | -50.28% |
| Dec 31, 2021 | 65.63M | -14.91% |
| Dec 31, 2020 | 77.13M | -1.12% |
| Oct 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 772.59B |
| Johnson & Johnson | 455.04B |
| AbbVie | 385.18B |
| UnitedHealth Group | 309.40B |
| AstraZeneca | 253.98B |
| Novartis AG | 237.13B |
| Novo Nordisk | 216.87B |
| Abbott Laboratories | 214.96B |